Evidence map›Paper›PMID 36933137›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2023

Is oropharyngoesophageal scintigraphy the method of choice for assessing dysphagia in systemic sclerosis? A single center experience.

Marco Di Battista, Mariano Grosso, Mattia Da Rio, Giammarco De Mattia, Andrea Marciano, Anastasiya Valevich, Antonio Grosso, Riccardo Morganti, Duccio Volterrani, Alessandra Della Rossa and 1 more

Abstract read
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marco Di BattistaRheumatology Unit, University of Pisa, Via Roma 67, 56123, Pisa, Italy. dibattista.marco91@gmail.com.ORCID 0000-0002-4788-5729
Mariano GrossoNuclear Medicine, Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy.
Mattia Da RioRheumatology Unit, University of Pisa, Via Roma 67, 56123, Pisa, Italy.
Giammarco De MattiaRheumatology Unit, University of Pisa, Via Roma 67, 56123, Pisa, Italy.
Andrea MarcianoNuclear Medicine, Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy.
Anastasiya ValevichRheumatology Unit, University of Pisa, Via Roma 67, 56123, Pisa, Italy.
Antonio GrossoDepartment of Translational Sciences and New Technologies in Medicine and Surgery, Gastrointestinal Unit, University of Pisa, Pisa, Italy.
Riccardo MorgantiSection of Statistics, University of Pisa, Pisa, Italy.
Duccio VolterraniNuclear Medicine, Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy.
Alessandra Della RossaRheumatology Unit, University of Pisa, Via Roma 67, 56123, Pisa, Italy.
Marta MoscaRheumatology Unit, University of Pisa, Via Roma 67, 56123, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the performance of oropharyngoesophageal scintigraphy (OPES) in the assessment of dysphagia in patients with systemic sclerosis (SSc), and to compare OPES results with those of barium esophagogram.

methodsAdult SSc patients who underwent OPES for the assessment of dysphagia were enrolled. OPES was performed with both liquid and semisolid boluses and provided information regarding oropharyngeal transit time, esophageal transit time (ETT), oropharyngeal retention index (OPRI), esophageal retention index (ERI), and site of bolus retention. Barium esophagogram results were also collected.

resultsFifty-seven SSc patients (87.7% female, mean age 57.7 years) with dysphagia were enrolled. OPES identified at least one alteration in each patient and findings were generally worse for the semisolid bolus. Esophageal motility was widely impaired with 89.5% of patients with an increased semisolid ERI, and middle-lower esophagus was the most frequent site of bolus retention. However, oropharyngeal impairment was highlighted by widespread increased OPRI, especially in anti-topoisomerase I positivity. Older patients and with longer disease duration presented slower semisolid ETT (p = 0.029 and p = 0.002, respectively). Eleven patients with dysphagia had a negative barium esophagogram: all of them presented some alterations in OPES parameters.

conclusionOPES revealed a marked SSc esophageal impairment, in terms of both slowed transit time and increased bolus retention, but also shed light on oropharyngeal swallowing alterations. OPES showed high sensitivity, being able to detect swallowing alterations in dysphagic patients with negative barium esophagogram. Therefore, the use of OPES for the assessment of SSc-related dysphagia in clinical practice should be promoted.

Indexed as

Deglutition DisordersScleroderma, SystemicAdultBariumFemaleHumansMaleMiddle AgedRadionuclide ImagingBariumBarium esophagogramDysphagiaOropharyngoesophageal scintigraphySystemic sclerosis

Identifiers

PMID36933137
PMCPMC10234875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.